Circulating IgA/IgG memory B cells against Mycobacterium tuberculosis dormancy-associated antigens Rv2659c and Rv3128c in active and latent tuberculosis

• Published in: International journal of infectious diseases Vol. 110; pp. 75 - 82
• Main Authors: Soe, Phyu Thwe, Hanthamrongwit, Jariya, Saelee, Chutiphon, Kyaw, Soe Paing, Khaenam, Prasong, Warit, Saradee, Satproedprai, Nusara, Mahasirimongkol, Surakameth, Yanai, Hideki, Chootong, Patchanee, Leepiyasakulchai, Chaniya
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01-09-2021; Elsevier
• Subjects: Latent tuberculosis infection; Memory B cells; Rv2659c; Rv3128c; Rv2659c; Rv3128c; Memory B cells; Latent tuberculosis infection
• ISSN: 1201-9712; 1878-3511
• DOI: 10.1016/j.ijid.2021.07.033

•The number of Rv2659c IgA B cells was significantly higher in latent tuberculosis.•Latent tuberculosis exhibited remarkable elevation of classical memory B cells.•IgA+ classical memory B cells were predominant in the latent tuberculosis group.
To elucidate the antigenic potential of dormancy-associated antigens Rv2659c and Rv3128c of Mycobacterium tuberculosis by examining the persistence of specific IgG and IgA memory B cells (MBCs) among patients with active tuberculosis (TB), household contacts with latent tuberculosis (LTBI), and an endemic healthy control group.
Fresh peripheral blood mononuclear cells from the three study groups were used to enumerate the numbers of IgG and IgA MBCs specific to recombinant protein Rv2659c and Rv3128c by ELISpot assay. The composition of MBC subsets IgA+ and IgG + was analyzed by flow cytometry.
The number of IgA MBCs specific to antigen Rv2659c was significantly higher in the LTBI group than the TB group. In contrast, no significant difference was found in IgA or IgG MBCs against antigen Rv3128c. The number of IgA+ MBCs was significantly higher than that of IgG+ MBCs in the classical MBC subset of the LTBI group.
The results indicated that the dormancy-associated antigen Rv2659c induced an IgA MBCs response in individuals with latent TB, and IgA+ classical MBCs formed a major portion of the MBCs subset. This new knowledge will be beneficial for the development of novel TB vaccines and their control of latent TB.